NCT06223048View on ClinicalTrials.gov

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 7, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

February 28, 2025

Conditions
Primary Open Angle Glaucoma
Interventions
DRUG

AMDX-2011P

AMDX-2011P single bolus injection intravenous for diagnostic review

Trial Locations (3)

85020

RECRUITING

Associated Retina Consultants, Phoenix

91204

RECRUITING

Global Research Management, Glendale

92663

RECRUITING

Eye Research Foundation, Newport Beach

All Listed Sponsors
lead

Amydis Inc.

INDUSTRY